JulieRGralowMD

Oncology • Alexandria, VA

Hematologic Oncology

Chief Medical Officer, American Society of Clinical Oncology (ASCO)

Join to view full profile

Dr. Gralow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gralow's full profile

Already have an account?

Office
2318 Mill Road suite 800
Alexandria, VA 22314
Phone+1 571-483-1650

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1992 - 1995
Brigham and Women's HospitalResidency, Internal Medicine, 1989 - 1991
Brigham and Women's HospitalInternship, Internal Medicine, 1988 - 1989
Keck School of Medicine of the University of Southern CaliforniaClass of 1988
Stanford UniversityBS, Biology, 1977 - 1981

Certifications & Licensure

WA State Medical License 1992 - 2027
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Humanitarian Award ASCO, 2018
America's Top Doctors Castle Connolly, 2008-2018
America's Top Doctors for Cancer Castle Connolly, 2007-2018
Fellow (FACP) American College of Physicians, 2008
University of Washington Medical Center Service Excellence Award 2008
Fellow (FASCO) American Society of Clinical Oncologists, 2008
American Society of Clinical Oncology Statesman Award 2008
Finding Your Way To Wellness 2007
Women of Valor Medicine and Health Care, Washington State, 2006
Susan G. Komen for the Cure, Puget Sound Affiliate, C.J. Taylor Outstanding Community Volunteer Award 2005
Above and Beyond The Breast Care Site, 2005
University of Washington Continuing Medical Education Department Outstanding Faculty Award 2000
Coping Magazine Honorary Hero 1999
American Cancer Society Clinical Career Development Award 1995-1997, 1998
American Society of Clinical Oncology Career Development Award 1995-1997, 1998
Upjohn Outstanding Oncology Fellow Award 1994
U.S.C. School of Medicine Dean's List 1984-1987, 1988
Irving I. Lasky Award for Medical Student Research 1988
Janet M. Glasgow/American Medical Women's Association Achievement Award 1988
U.S.C. Summer Research Fellowship Award 1984-1985, 1986
Alpha Omega Alpha Honor Medical Society 1986
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer Start of enrollment: 2001 Jan 01
Completed
Phase 3
S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer Start of enrollment: 2001 May 01
Completed
Phase 2
Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer Start of enrollment: 2001 Sep 01
Completed
Phase 3
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial Start of enrollment: 2001 Mar 01
Terminated
Phase 1, Phase 2
S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. Start of enrollment: 2005 Jul 01
Completed
Phase 3
Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer Start of enrollment: 1997 Nov 01
Completed
Phase 2
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
Completed
S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer Start of enrollment: 2012 May 16
Completed
Not Applicable
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Active, not recruiting
Phase 3
Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors Start of enrollment: 2018 Apr 18
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial.
Yara Abdou, William E Barlow, Julie R Gralow, Funda Meric-Bernstam, Kathy S Albain
Journal of the National Cancer Institute. 2024-12-05
Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis.
Eileen Morgan, Colette O'Neill, Richa Shah, Oliver Langselius, Yaqi Su
Breast Cancer Research. 2024-11-27
Collecting Long-Term Outcomes in Population-Based Cancer Registry Data: The Case of Breast Cancer Recurrence.
Eileen Morgan, Colette O'Neill, Aude Bardot, Paul Walsh, Ryan R Woods
JCO Global Oncology. 2024-10-01

Journal Articles

Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230
Carol J Fabian, Julie R Gralow, Journal of the National Cancer Institute
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer
Aminah Jatoi, Antonio C Wolff, Harvey Jay Cohen, Rachel A Freedman, Gustav Magrinat, Julie Gralow, Gretchen Kimmick, Heidi D Klepin, Harold Burstein, Hyman Muss, Jeann..., Journal of the American Geriatrics Society
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemothe...
Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh IT, Ravdin P, Bugarini R, Baehner FL, Davidson NE, Sledge GW, Winer EP, Hudis C, Ingle JN, Perez EA, Pr..., Lancet Oncol
Intensive dose-dense compared with high-dose adjuvant chemotherapy for high risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.
Moore H, Green SJ, Gralow JR, Bearman SI, Lew D, Barlow WE, Hudis C, Wolff AC, Ingle JN, Chew HK, Elias AD, Livingston RB, Martino S, J Clin Oncol
Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy.
Sparano JA, Pisano ED, White JR, Hunt KK, Mamounas EP, Perez EA, Hortobagyi GN, Gralow JR, Comis RL, Breast Cancer Res Treat
Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic ...
Sparano JA, Hortobagyi GN, Gralow JR, Perez EA, Comis RL, Breast Cancer Res Treat
Early detection of breast cancer: new biomarker tests on the horizon?
Jotwani AC, Gralow JR, Mol Diagn Ther
Effects of Denosumab in Patients with Bone Metastases, with and without Previous Bisphosphonate Exposure.
Body JJ, Lipton A, Gralow J, Steger GG, Gao G, Yeh H, Fizazi K, J Bone Miner Res
Adjuvant chemotherapy in older women with early-stage breast cancer.
Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP, Kartcheske PA, Wheeler JD, Perez EA, Wolff AC,..., N Engl J Med
Breast Cancer Advocacy: Changing Perceptions.
Koon K, Soldak T, Gralow J, PMID
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening - a report from the American Society of Clinical Oncology.
Winer E, Gralow J, Diller L, Karlan B, Loehrer P, Pierce L, Demetri G, Ganz P, Kramer B, Kris M, Markman M, Mayer R, Pfister D, Raghavan D, Ramsey S, Reaman G, Sandler..., J Clin Oncol
A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.
Chew HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow J, Hortobagyi GN, Livingston R, Clin Breast Cancer
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compare...
Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J, Dickler M, Perez EA, Cobleigh M, Shenkier T, Edgerton S, M..., J Clin Oncol
Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer.
Bunnell C, Vahdat L, Schwartzberg L, Gralow J, Klimovsky J, Poulart V, Peck R, Thomas E, Clin Breast Cancer
Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies.
Coleman RE, Body JJ, Gralow JR, Lipton A, Cancer Treat Rev
Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtable.
Gralow J, Rugo H, Gradishar W, O'Shaughnessy JA, Jahanzeb M, Perez E, Tripathy D, Clin Breast Cancer
Major depression after breast cancer: a review of epidemiology and treatment.
Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, Gralow J, Gen Hosp Psychiatry
Major Research Advances in Cancer Treatment, Prevention, and Screening: A Report from the American Society of Clinical Oncology.
Grralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winer EP, Bonner J, Demetri GD, Curran W Jr, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Rams..., J Clin Oncol
Patient training in cancer pain management using integrated print and video materials: A multisite randomized controlled trial.
Syrjala KL, Abrams JR, Polissar NL, Hansberry J, Robison J, Dupen S, Stillman M, Fredrickson M, Rivkin S, Feldman E, Gralow J, Rieke JW, Raish RJ, Lee DJ, Cleeland CS,..., Pain
Helping her heal: A pilot study of an educational counseling intervention for spouses of women with breast cancer.
Lewis FM, Cochrane BB, Fletcher KA, Zahlis EH, Shands ME, Gralow JR, Wu SM, Schmitz K, Psychooncology
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez EA, Shenkier T, Cella D, Davidson NE, N Engl J Med
Guidance on the use of bisphosphonates in solid tumors: recommendations of an international expert panel.
Aapro M, Abrahamsson PA, Body JJ, Coleman RE, Colomer R, Costa L, Crinò L, Dirix L, Gnant M, Gralow J, Hadji P, Hortobagyi GN, Jonat W, Lipton A, Monnier A, Paterson A..., Ann Oncol
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening - A report from the American Society of Clinical Oncology.
Ozols RF, Herbst RS, Colson YL, Gralow J, Bonner J, Curran WJ Jr, Eisenberg BL, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Reaman GH, Sawaya R, Schi..., J Clin Oncol
Serial 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progre...
Specht JM, Tam SL, Kurland BF, Gralow JR, Livingston RB, Linden HM, Ellis GK, Schubert EK, Dunnwald LK, Mankoff DA, Breast Cancer Res Treat
Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV, Rieger PT, Shockney LD, Shulman LN, Soldak T, Thomas DB, ..., Breast
Join now to see all

Books/Book Chapters

Medical Therapeutics.
Chapter: Oncologic Therapeutics
Gralow JR, Livingston RL, Hunt K, Petersdorf SEditors: Ramsey P and Larson EB.W.B. Saunders Co
Cancer Patient Follow-Up.
Chapter: Breast Cancer Patient Follow-Up
Gralow JR, Anderson BOEditors: Johnson, F. and Virgo, K.S.Moseby-Year Book, Inc
Vaccines Against Virally Induced Cancers.
Chapter: Immunity to the HER-2/neu Oncogenic Protein
Page 198 - 211Disis ML, Bernhard H, Gralow JR, Hand SL, Emery SR, Calenoff E, Cheever MAJohn Wiley & Sons, Inc
Proceedings of the Second International Conference on Malignant Lymphoma.
Chapter: The Immunology of B-Cell Lymphoma. Studies with Anti-Idiotype Antibodies
Levy R, Meeker TC, Lowder JN, Maloney D, Thielmans K, Gralow J, Warnke R, Cleary ML, Sklar JMartinus Nishoff Publishing, Boston, MA
Finding Your Way to Wellness: A Puget Sound Breast Cancer Information and Resource guide.
Gralow JRPeanut Butter Publishing
Finding Your Way to Wellness: A Puget Sound Breast Cancer Information and Resource guide.
Gralow JREditors: Susan G.Komen Breast Cancer FoundationEdition 3rd,
Diseases of the Breast.
Chapter: Adjuvant Systemic Therapy: Bisphosphonates
Gralow JREditors: Harris JR, Lippman ME, Morrow M, Osborne CK.Lippincott, Williams & WilkinsEdition 4th,
Principles and Practice of Fertility Preservation.
Chapter: Breast cancer therapy and reproduction
Page 62 - 72Korde L, Gralow JREditors: Donnez J and Kim SS.Cambridge University Press
Cancer rehabilitation and survivorship: Transdisciplinary approaches to personalized care.
Chapter: Recurrence and second primary cancers
Koon KP, Gralow JREditors: J.L. Lester & P. Schmitt.Oncology Nursing Society, Pittsburgh, PA
Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries.
Chapter: Core elements for provision of cancer care and control in low and middle income countries
Shulman L, Gralow J, Krakauer E, Anderson BO, Porter P, Gospodarowicz M, Feldman S, Rodriguez-Galindo C, Frazier L, Lehmann LEditors: Knaul FM, Frenk, J, Shulman L.Harvard Global Equity Initiative, Boston, MA
Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries.
Chapter: Innovative delivery of cancer care and control in low-resource scenarios
Knaul FM, Bhadelia A, Gralow J, Langer AEditors: Knaul FM, Frenk, J, Shulman L.Harvard Global Equity Initiative, Boston, MA
Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries.
Chapter: Access to affordable medicines, vaccines, and health technologies for cancer: overcoming price and non-price barriers to access
Quick J, Konduri N, Gralow JEditors: Knaul FM, Frenk, J, Shulman L.Harvard Global Equity Initiative, Boston, MA
Closing the Cancer Divide: An Equity Imperative.
Knaul FM, Gralow JR, Atun R, Bhadelia AHarvard University Press, Boston, MA
Join now to see all

Abstracts/Posters

Spontaneous and Induced Immunoglobulin Secretion and Differentiation in Human B-Cell Lymphomas and Leukemias.
Gralow J, Levy R, Miller RA, Federation Proceedings, Federation of American Societies for Experimental Biology
Southern Blotting of DNA from Formalin-Fixed, Paraffin Embedded Tissue.
Dubeau L, Chandler L, Gralow J, Nichols PW, Jones PA, International Academy of Pathology
Recovery of Intact, High Molecular Weight DNA from Formalin-Fixed, Paraffin Embedded Pathology Specimens.
Dubeau L, Chandler L, Gralow J, Nichols PW, Jones PA, American Urological Association
Methylation Patterns of the Alpha-Lactalbumin Gene in Human Mammary Carcinoma: A Model for Identification of the Origin of Metastatic Tumors.
Gralow JR, Dubeau L, Jones PA, Clinical Research
Existent T cell and Antibody Immunity to HER-2/neu Protein in Breast Cancer Patients.
Disis ML, Bernhard H, Gralow JR, Cheever MA, The American Association for Cancer Research
Immunization to oncogenic HER-2/neu protein with peptide based vaccines.
Disis ML, Gralow JR, Bernhard H, Hand S, and Cheever MA, The American Association for Cancer Research
Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
Bernhard H, Disis ML, Huseby E, Hand S, Gralow JR, Risdon G, Heimfeld S, and Cheever MA, Keystone Symposia
HER-2/neu Specific Immunity Can Be Induced by Therapy with 2B1, a Bispecific Antibody Binding to HER-2/neu and CD16.
Gralow JR, Weiner LM, Ring D, Clark J, Alpaugh RK, Disis ML, Cheever MA, IVth International Conference on Bispecific Antibodies and Targeted Cellular Toxicity
GM-CSF: An effective adjuvant for peptide based vaccines.
Disis ML, Bernhard H, Shiota F, Hand S, Gralow JR, and Cheever MA, The Ninth International Congress of Immunology
Bispecific Monoclonal Antibody-Promoted Induction of the Idiotype Cascade in a Phase I Clinical Trial.
Clark JI, Gralow JR, Alpaugh RK, Disis ML, Cheever MA, Ring D, and Weiner LM, The American Association for Cancer Research
Therapeutic Efficacy of Doxorubicin Immunoconjugates Targeting the HER-2/neu Oncogenic Protein in a Human Breast Cancer Cell Line.
Specht JS, Sivam GP, Gralow JR, Journal of Investigative Medicine
[Tc-99M]-Sestamibi Scintimammography to Measure the Breast Cancer Response to Neo-Adjuvant Chemotherapy.
Mankoff DA, Gralow JR, Dunnwald LK, Drucker MJ, Ellis G, Livingston RB, Journal of Nuclear Medicine
Monitoring Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients Using [Tc-99m]-Sestamibi Scintimammography.
Mankoff DA, Gralow JR, Dunnwald LK, Drucker MJ, Ellis G, Livingston RB, The American Society of Clinical Oncology
Monitoring and Predicting the Response of Breast Cancer to Neo-adjuvant Chemotherapy Using [TC99m]-Setstamibi Scintimammography.
Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Drucker MJ, Livingston R, Society of Nuclear Medicine
Taxol by 96-hour Infusion and Sequential Navelbine with GCSF Support as Salvage Therapy for Breast Cancer. A Phase I-II Study.
Livingston RB, Gralow JR, Ellis GK, Williams MA, Bristol Myers Squibb Investigator’s Meeting
The Role of Imaging Modalities in the Diagnosis and Treatment of Breast Cancer.
Gralow JR, Mankoff DA, Society of Nuclear Medicine, Western Section
Combined PET and Surface Coil MRI Imaging in the Diagnosis of Recurrent Breast Cancer in the Axilla.
Mankoff DA, Maravilla K, Austin-Seymour M, Ellis GK, Hayes C, Gralow JR, Cortese AA, Moe R, San Antonio Breast Cancer Symposium
Therapeutic Efficacy of Doxorubicin Immunoconjugates Targeting the HER-2/neu Oncogenic Protein in Human Breast Cancer.
Specht JS, Sivam GP, Gralow JR, the American Society of Clinical Oncology
Cellular Tumor Markers as Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer.
Zapf ML, Folpe AL, Storer BE, Gown AM, Ellis GK, Livingston RB, Gralow JR, Breast Ca Res and Treat
Monitoring Locally Advanced Breast Cancer Treatment Response using [Tc-99m]-Sestamibi scintimammography.
Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Drucker MJ, Livingston R, Breast Ca Res and Treat
Continuous Adriamycin and Cyclophosphamide with GCSF Feasible with High Dose Intensity, Low Risk of Hospitalization.
Ellis GK, Williams M, Gralow J, Long C, Livingston RB, Breast Ca Res and Treat
Alterations in Breast Cancer Protein Expression Following Neoadjuvant Doxorubicin-based Chemotherapy.
Gralow JR, Zapf ML, Folpe AL, Ellis GK, Livingston RB, Gown AM, Breast Ca Res and Treat
IL-12 Induces Cytolytic Activity in Lymphocytes from Breast Cancer Patients after High Dose Therapies.
Lindgren C, Markowitz D, Gralow J, Keeler T, Bennett S, Golden J, Bensinger W, Holmberg L, Thompson JA, Fefer A, the American Society of Clinical Oncology
Breast Cancer Tumor Associated Proteins as Predictors of Response to Neoadjuvant Doxorubicin-Based Chemotherapy.
Zapf ML, Folpe AL, Storer BE, Gown AM, Ellis GK, Livingston RB, Gralow JR, the American Society of Clinical Oncology
Paclitaxel/Vinorelbine Chemotherapy with Concurrent G-CSF for Metastatic Breast Cancer: Phase I-II Study in Doxorubicin-Treated Patients.
Ellis GK, Gralow JR, Pierce HI, Williams MA, Livingston RB, the American Society of Clinical Oncology
Join now to see all